Across TCGA pan-cancer cohorts, RNA5SP50 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNA5SP50 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNA5SP50 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP50 expression acts as an unfavorable survival marker.
LUAD are the cancer types where RNA5SP50 RNA most reproducibly stratifies survival.